Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
about
sameAs
Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesAspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health studyFactors driving the aspirin exacerbated respiratory disease phenotype.Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccinationFatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease.Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study.Aspirin use and risk of atrial fibrillation in the Physicians' Health Study.Clinical applications of drug desensitization in the Asia-Pacific region.STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects.Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models.Current status and challenges of cytokine pharmacology.Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.The management of eosinophilic gastroenteritis.Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics.Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory diseaseEfficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
P2860
Q26750424-6EEDF7E7-E7BC-41B4-B2B1-228478B7FCFDQ28201262-322676D9-B6D4-4313-9142-3DFF13796097Q30300955-FC4D697F-7540-409C-9D7B-71881726655EQ30428747-0C5E74CB-B78A-4C50-A07C-F92FC2665D60Q33932627-C14A62EF-71FC-42B1-BE99-77FE044FEB47Q33988507-FA66528D-1CFB-4589-96F6-A747ACEA65CDQ34343159-BAB3CE09-4E0E-43C2-A252-0E95AB492C5FQ35026193-3539A1DF-B026-4FB3-96A2-62EE9AEC2841Q35502326-0AC0D8D1-BFB2-48A7-8D9B-BC3720DE3815Q36000599-F0E4FE30-852F-4705-B39F-66F76D95A093Q37073991-B9D8A79C-45E4-4F01-8754-7E3CDC9F1E66Q37310533-C8385012-869E-49CF-902F-4055F167464AQ37393529-E6439AC7-A6D9-43D2-95A4-5404ECF960FEQ37445966-F27AB0BE-D11F-4C1E-BE86-60534BC6591DQ38062847-27023194-65F2-4179-BEDD-ED05B539D18DQ38509377-E2696106-8BC3-4BC9-87C9-542BE6368AA2Q39811129-225A1F56-5EA8-4C0E-BA01-4177838FF57CQ42129014-A52A6FB0-9FD7-411B-BE27-3558945C6E8FQ46319705-9CF701B5-33CF-46C2-B02E-84556509078FQ52147501-3D029623-7CE0-4395-BD9E-1B78940F7EA1
P2860
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@ast
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@en
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@nl
type
label
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@ast
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@en
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@nl
prefLabel
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@ast
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@en
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@nl
P2093
P1476
Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6
@en
P2093
Achsah D Keegan
Jose Zamorano
Marco Melo
Moises Perez-G
P304
P356
10.4049/JIMMUNOL.168.3.1428
P407
P577
2002-02-01T00:00:00Z